Mo Chen
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism 13
- Molecular Biology top 1%
- RNA Research and Splicing 10
- RNA modifications and cancer 9
- Epigenetics and DNA Methylation 9
- Cancer-related gene regulation 8
- Rheumatology top 1%
- Oncology top 5%
- Genetics top 2%
-
- Acute Myeloid Leukemia Research 14
- Hematopoietic Stem Cell Transplantation 9
-
- Aldose Reductase and Taurine 10
- Co-authors
- James L. ManleyCharles J. DavidPeter CanollMarcela C. AssanahRegis J. O’KeefeDi ChenT.M. PenningJian Zhang
- Journals
- Journal of Biological Chemistry (3 papers)Chemico-Biological Interactions (3 papers)Blood (3 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Mo Chen
170 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 173
- Cancer Research 1.6k
- Molecular Biology 4.9k
- Rheumatology 714
- Oncology 958
- Genetics 353
Countries citing papers authored by Mo Chen
This map shows the geographic impact of Mo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mo Chen more than expected).
Fields of papers citing papers by Mo Chen
This network shows the impact of papers produced by Mo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mo Chen. The network helps show where Mo Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mo Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 5 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 18 | |
| 11 | 2023 | 6 | |
| 12 | 2022 | 9 | |
| 13 | 2021 | 11 | |
| 14 | 2020 | 60 | |
| 15 | 2020 | 34 | |
| 16 | 2019 | 24 | |
| 17 | 2014 | 29 | |
| 18 | 2013 | 62 | |
| 19 | 2008 | 390 | |
| 20 | Directed graph embedding | 2007 | 40 |
About Mo Chen
Mo Chen is a scholar working on Hematology, Cancer Research and Molecular Biology, having authored 180 papers that have together received 7.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (14 papers), Cancer, Hypoxia, and Metabolism (13 papers), RNA Research and Splicing (10 papers), Aldose Reductase and Taurine (10 papers), RNA modifications and cancer (9 papers), Hematopoietic Stem Cell Transplantation (9 papers), Epigenetics and DNA Methylation (9 papers) and Cancer-related gene regulation (8 papers). The work is most often cited by research in Cancer Research (1.6k citations), Molecular Biology (4.9k citations) and Rheumatology (714 citations). Mo Chen has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include James L. Manley, Charles J. David, Peter Canoll, Marcela C. Assanah, Regis J. O’Keefe, Di Chen, T.M. Penning, Jian Zhang, Jeremy J. Mao and Yun-Han Huang. Their work appears in journals such as Journal of Biological Chemistry, Chemico-Biological Interactions, Blood, The FASEB Journal and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.